The induction of DNA double strand breaks (DSBs) by chemotherapeutic drugs has been shown to activate a cytoplasmic DNA damage response, i.e. the GOLPH3/MYO18A/F-actin pathway, to promote Golgi apparatus dispersal and cancer cells survival5. Here, MYO18A is linked to cancer.